Skip to main content

Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands.

Publication ,  Journal Article
Norris, JD; Joseph, JD; Sherk, AB; Juzumiene, D; Turnbull, PS; Rafferty, SW; Cui, H; Anderson, E; Fan, D; Dye, DA; Deng, X; Kazmin, D ...
Published in: Chem Biol
April 24, 2009

The pharmacological activity of different nuclear receptor ligands is reflected by their impact on receptor structure. Thus, we asked whether differential presentation of protein-protein interaction surfaces on the androgen receptor (AR), a surrogate assay of receptor conformation, could be used in a prospective manner to define the pharmacological activity of bound ligands. To this end, we identified over 150 proteins/polypeptides whose ability to interact with AR is influenced in a differential manner by ligand binding. The most discriminatory of these protein-AR interactions were used to develop a robust compound-profiling tool that enabled the separation of ligands into functionally distinguishable classes. Importantly, the ligands within each class exhibited similar pharmacological activities, a result that highlights the relationship between receptor structure and activity and provides direction for the discovery of novel AR modulators.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Chem Biol

DOI

EISSN

1879-1301

Publication Date

April 24, 2009

Volume

16

Issue

4

Start / End Page

452 / 460

Location

United States

Related Subject Headings

  • Transcription, Genetic
  • Structure-Activity Relationship
  • Receptors, Androgen
  • Protein Interaction Mapping
  • Protein Conformation
  • Protein Binding
  • Organic Chemistry
  • Ligands
  • Humans
  • Cell Proliferation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Norris, J. D., Joseph, J. D., Sherk, A. B., Juzumiene, D., Turnbull, P. S., Rafferty, S. W., … McDonnell, D. P. (2009). Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands. Chem Biol, 16(4), 452–460. https://doi.org/10.1016/j.chembiol.2009.01.016
Norris, John David, James David Joseph, Andrea Barreto Sherk, Dalia Juzumiene, Philip Stewart Turnbull, Stephen William Rafferty, Huaxia Cui, et al. “Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands.Chem Biol 16, no. 4 (April 24, 2009): 452–60. https://doi.org/10.1016/j.chembiol.2009.01.016.
Norris JD, Joseph JD, Sherk AB, Juzumiene D, Turnbull PS, Rafferty SW, et al. Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands. Chem Biol. 2009 Apr 24;16(4):452–60.
Norris, John David, et al. “Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands.Chem Biol, vol. 16, no. 4, Apr. 2009, pp. 452–60. Pubmed, doi:10.1016/j.chembiol.2009.01.016.
Norris JD, Joseph JD, Sherk AB, Juzumiene D, Turnbull PS, Rafferty SW, Cui H, Anderson E, Fan D, Dye DA, Deng X, Kazmin D, Chang C-Y, Willson TM, McDonnell DP. Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands. Chem Biol. 2009 Apr 24;16(4):452–460.

Published In

Chem Biol

DOI

EISSN

1879-1301

Publication Date

April 24, 2009

Volume

16

Issue

4

Start / End Page

452 / 460

Location

United States

Related Subject Headings

  • Transcription, Genetic
  • Structure-Activity Relationship
  • Receptors, Androgen
  • Protein Interaction Mapping
  • Protein Conformation
  • Protein Binding
  • Organic Chemistry
  • Ligands
  • Humans
  • Cell Proliferation